Description
This book updates the ophthalmologist on the latest clinical and experimental developments in the management of proliferative vitreoretinopathy (PVR). It covers a broad spectrum of subjects relating to PVR and correlates current management with grades of severity of PVR. Noted authorities who have extensive clinical and experimental experience with PVR describe their current thinking. The present status of pharmacologic treatment and new concepts in the pathobiology of PVR are explored.